TechHR
ex
L&D
UNPLUGGED
Sphere
About Us • Contact Us
People Matters ANZ
People Matters Logo
Login / Signup
People Matters Logo
Login / Signup
  • Current
  • Top Stories
  • News
  • Magazine
  • Research
  • Events
  • Videos
  • Webinars
  • Podcast

© Copyright People Matters Media Pte. Ltd. All Rights Reserved.

 

 

  • HotTopic
    HR Folk Talk FutureProofHR
  • Strategy
    Leadership Csuite StrategicHR EmployeeRelations BigInterview
  • Recruitment
    Employer Branding Appointments Permanent Hiring Recruitment
  • Performance
    Skilling PerformanceMgmt Compensation Benefits L&D Employee Engagement
  • Culture
    Culture Life@Work Diversity Watercooler SheMatters
  • Tech
    Technology HR Technology Funding & Investment Startups Metaverse
  • About Us
  • Advertise with us
  • Become a sponsor
  • Contact Us
  • Feedback
  • Write For Us

Follow us:

Privacy Policy • Terms of Use

© Copyright People Matters Media Pte. Ltd. All Rights Reserved.

People Matters Logo
  • Current
  • Top Stories
  • News
  • Magazine
  • Research
  • Events
  • Videos
  • Webinars
  • Podcast
Login / Signup

Categories:

  • HotTopic
    HR Folk Talk FutureProofHR
  • Strategy
    Leadership Csuite StrategicHR EmployeeRelations BigInterview
  • Recruitment
    Employer Branding Appointments Permanent Hiring Recruitment
  • Performance
    Skilling PerformanceMgmt Compensation Benefits L&D Employee Engagement
  • Culture
    Culture Life@Work Diversity Watercooler SheMatters
  • Tech
    Technology HR Technology Funding & Investment Startups Metaverse
Blackstone to acquire Nucleus Network, Australia’s largest phase one clinical trials specialist

News • 29th Oct 2021 • 2 Min Read

Blackstone to acquire Nucleus Network, Australia’s largest phase one clinical trials specialist

Strategic HRFunding & Investment#MergersAndAcquisitions

Author: Ajinkya Salvi Ajinkya Salvi
4K Reads
The recent move is another feather in the series of acquisitions by Blackstone, which has a strong track record of investing in healthcare and life sciences in Asia and around the world.

Blackstone has announced that it has entered into a definitive agreement to acquire Nucleus Network, Australia’s largest phase one clinical trials provider with world-class facilities in Melbourne, Brisbane and Minneapolis. 

The recent move is another feather in the series of acquisitions by Blackstone, which has a strong track record of investing in healthcare and life sciences in Asia and around the world. Earlier this year, it completed the corporate carveout of Alinamin Pharmaceutical in Japan in the largest private equity deal in the country since 2017. In 2020, Blackstone invested in Precision Medicine Group, a next-generation life sciences services and technology company that helps biopharmaceutical companies design and conduct complex biomarker-based clinical trials and bring innovative therapies to market.

Cameron Johnson, Chief Executive Officer of Nucleus Network, said, “After five years of substantial growth, this new partnership with Blackstone is a perfect match for Nucleus Network. We are excited to leverage Blackstone’s expansive global network and significant experience in the life sciences sector to accelerate our next phase of global growth in phase one clinical trial delivery.” 

Life sciences is one of Blackstone’s highest conviction investment themes. In addition to substantial capital invested across Private Equity, Real Estate and Credit strategies, Blackstone’s specialist Life Sciences investment platform (BXLS) has more than $7 billion in assets under management and helps bring to market promising new medicines and medical technologies. In July 2020, BXLS raised the largest private life sciences fund to date. 

James Carnegie, Head of Private Equity, Blackstone Australia, said: “We look forward to working with Cameron Johnson and his outstanding team to help Nucleus enter its next phase of growth, combining the domain expertise and scale of the Blackstone Life Sciences network with their talent, experience and enthusiasm. We’re proud to back one of Australia’s market leading phase one clinical trials providers as they look to expand and serve the rapidly growing biotech market both here and internationally.” 

Over the last 15 years, Nucleus has helped deliver more than 800 phase one clinical trials, supporting the commercialization of innovative new medicines and therapies. With its exceptional clinical and regulatory expertise, it has become a trusted specialist partner to biotech companies and research hospitals around the world

Read More

Did you find this article helpful?


You Might Also Like

UBS initiates fresh layoffs including top managers

NEWS • 28th Jan 2025 • 2 Min Read

UBS initiates fresh layoffs including top managers

Strategic HRTalent Management#Layoffs#HRCommunity
68% of HR professionals struggle to find talent

NEWS • 16th Jan 2025 • 3 Min Read

68% of HR professionals struggle to find talent

Strategic HRRecruitment#HRTech#HRCommunity
NZ to ease dismissal rules for high-paid employees

NEWS • 9th Dec 2024 • 2 Min Read

NZ to ease dismissal rules for high-paid employees

Strategic HREmployment Landscape#HRTech#HRCommunity
NEXT STORY: AWS to invest NZ$7.5b in New Zealand, train people with in-demand digital skills

Trending Stories

  • design-thinking-hr

    ChatGPT Walks It Back — AI Giants Race Ahead

  • design-thinking-hr

    Skype is dead: Did Microsoft's leadership let a billion-doll...

  • design-thinking-hr

    From copy-paste to creative spark: mastering generative AI i...

  • design-thinking-hr

    Keeping the C-suite in the C-suite - how do we reduce execut...

People Matters Logo

Follow us:

Join our mailing list:

By clicking “Subscribe” button above, you are accepting our Terms & Conditions and Privacy Policy.

Company:

  • About Us
  • Advertise with us
  • Become a sponsor
  • Privacy Policy
  • Terms of Use

Contact:

  • Contact Us
  • Feedback
  • Write For Us

© Copyright People Matters Media Pte. Ltd. All Rights Reserved.

Get the latest Articles, Insight, News & Trends from the world of Talent & Work. Subscribe now!
People Matters Logo

Welcome Back!

or

Enter your registered email address to login

Not a user yet? Lets get you signed up!

A 5 digit OTP has been sent to your email address.

This is so we know it's you. Haven't received it yet? Resend the email or then change your email ID.

People Matters Logo

Welcome! Let's get you signed up...

Starting with the absolulte basics.

Already a user? Go ahead and login!

A 5 digit OTP has been sent to your email address.

This is so we know it's you. Haven't received it yet? Resend the email or then change your email ID.

Let's get to know you better

We'll never share your details with anyone, pinky swear.

And lastly...

Your official designation and company name.